{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:03:41Z","timestamp":1790042621059,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.jaad.2007.05.021","type":"journal-article","created":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T07:22:43Z","timestamp":1182496963000},"page":"1046-1050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Sirolimus (rapamycin): From the soil of Easter Island to a bright future"],"prefix":"10.1016","volume":"57","author":[{"given":"Kapila V.","family":"Paghdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.05.021_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/med.20049","article-title":"Molecular activity of sirolimus and its possible applications in tuberous sclerosis treatment","volume":"26","author":"J\u00f3\u017awiak","year":"2006","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jaad.2007.05.021_bib2","series-title":"Rapamune [package insert]","year":"2006"},{"key":"10.1016\/j.jaad.2007.05.021_bib3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2133.2005.06438.x","article-title":"Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial","volume":"152","author":"Ormerod","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.05.021_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2230.2002.01148.x","article-title":"Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology","volume":"27","author":"Reynolds","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.05.021_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1365-2133.2001.04376.x","article-title":"Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial","volume":"145","author":"Reitamo","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.05.021_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2007.05.021_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaad.2007.05.021_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000099584","article-title":"Angioedema in renal transplant recipients on sirolimus","volume":"214","author":"Mahe","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.05.021_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2007.05.021_bib10","first-page":"S49","article-title":"Clinical and molecular insights into lymphangioleiomyomatosis","volume":"22","author":"Steagall","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.jaad.2007.05.021_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2007.05.004","article-title":"Tuberous sclerosis complex: advances in diagnosis, genetics and management","volume":"57","author":"Schwartz","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.05.021_bib12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.05.021_bib13","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/01.TP.0000115344.18025.0B","article-title":"Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma","volume":"77","author":"Campistol","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2007.05.021_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jso.20090","article-title":"Kaposi's sarcoma: an update","volume":"87","author":"Schwartz","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jaad.2007.05.021_bib15","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.94.3.979","article-title":"Vascular endothelial growth factor\/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma","volume":"94","author":"Masood","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2007.05.021_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/08860220601039528","article-title":"A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient","volume":"29","author":"Yilmaz","year":"2007","journal-title":"Ren Fail"},{"key":"10.1016\/j.jaad.2007.05.021_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1470-2045(06)70907-X","article-title":"Sirolimus monotherapy for Kaposi's sarcoma in an HIV-negative patient","volume":"7","author":"Weenink","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2007.05.021_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2007.05.021_bib19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00007890-200405150-00002","article-title":"Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice","volume":"77","author":"Koehl","year":"2004","journal-title":"Tranplantation"},{"key":"10.1016\/j.jaad.2007.05.021_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2002-12-3793","article-title":"Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis","volume":"102","author":"Xia","year":"2003","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.jaad.2007.05.021_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1468-3083.2006.01777.x","article-title":"New topical immunological treatments for psoriasis","volume":"20","author":"De Prost","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2007.05.021_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1067\/mai.2001.118796","article-title":"Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis","volume":"108","author":"Trautmann","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2007.05.021_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2133.2005.06745.x","article-title":"Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis","volume":"153","author":"Baumer","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.05.021_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/path.2081","article-title":"Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion","volume":"211","author":"Ong","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.jaad.2007.05.021_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1600-6143.2006.01648.x","article-title":"Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome","volume":"7","author":"Levi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaad.2007.05.021_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0190-9622(95)90017-9","article-title":"The Muir-Torre syndrome: a 25-year retrospect","volume":"33","author":"Schwartz","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2007.05.021_bib27","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/ndt\/gfm089","article-title":"Kaposi's sarcoma in renal transplant recipients\u2014the impact of proliferation signal inhibitors","volume":"22","author":"Campistol","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaad.2007.05.021_bib28","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.tp.0000260142.38619.9c","article-title":"Rapamycin inhibits proliferation of Epstein-Bar virus-positive B-cell lymphomas through modulation of cell-cycle protein expression","volume":"83","author":"Vaysberg","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2007.05.021_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0738-081X(02)00271-7","article-title":"New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications","volume":"20","author":"Assmann","year":"2002","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2007.05.021_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1368-5031.2005.00587.x","article-title":"Pimecrolimus in dermatology: atopic dermatitis and beyond","volume":"59","author":"Gisondi","year":"2005","journal-title":"Int J Clin Pract"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207008870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207008870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:08:03Z","timestamp":1759270083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207008870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0190962207008870"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.05.021","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus (rapamycin): From the soil of Easter Island to a bright future","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}